Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

The aim of the study is to evaluate the efficacy and safety of tralokinumab in adults with atopic dermatitis

Key facts

Study ID

NCT02347176

Run by

MedImmune LLC

People needed

204

Starts

2015-01-23

Expected to finish

2016-02-05

Last updated by the study team

2018-05-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Physician diagnosis of atopic dermatitis for greater than (>) 1 year
• Atopic dermatitis involvement of greater than or equal to (>=) 10 percent (%) body surface area
• EASI score of >= 12
• SCORAD of >= 25
• IGA score of >= 3
• Effective birth control in line with protocol details

You may not qualify if…

• History of anaphylaxis following any biologic therapy
• Hepatitis B, C or human immunodeficiency virus
• Pregnant or breastfeeding
• History of cancer
• Previous receipt of tralokinumab

Where it is running

• Research Site — Rogers, Arkansas, United States
• Research Site — Fremont, California, United States
• Research Site — Fullerton, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Oceanside, California, United States
• Research Site — Rancho Santa Margarita, California, United States
• Research Site — Santa Monica, California, United States
• Research Site — Clearwater, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Worcester, Massachusetts, United States
• Research Site — Warren, Michigan, United States
• Research Site — Berlin, New Jersey, United States
• Research Site — Verona, New Jersey, United States
• Research Site — New York, New York, United States
• Research Site — Rochester, New York, United States
• Research Site — Portland, Oregon, United States
• Research Site — Charleston, South Carolina, United States
• Research Site — Houston, Texas, United States
• Research Site — Houston, Texas, United States
• Research Site — Pflugerville, Texas, United States
• Research Site — San Antonio, Texas, United States
• Research Site — San Antonio, Texas, United States
• Research Site — Norfolk, Virginia, United States
• Research Site — East Melbourne, Australia
• Research Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.